It's worth noting that insurance may not cover these injections unless they're used to treat a specific medical condition
An OA mouse model was successfully established by injecting monosodium iodoacetate (MIA) in mouse knee joints 25 , specifically, involving anesthetic administration with 1.25% tribromoethanol (Bimake, M2920) at a dose of 0.2 mL/10 g body weight, followed by intra-articular injection of 10 L MIA (50 mg/ml, Sigma-Aldrich, 57858-25G-F) into the right knee joint using a 30-gauge needle
Patients begin at microdose strength (typically 0.25 mg weekly) and titrate upward as tolerated, allowing transplant nephrologists to monitor kidney labs and graft function at each step without surprise cost increases
Typically, stopping the medication will stop all side effects within a matter of weeks or months
Relationships between chemoreflex responses, sleep quality, and hematocrit in Andean men and women